StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) shareholders

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)

Close on Nov 17, 2026Market cap $28.91MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
45.3%
5M of 11M shares
Institutional holders
38
3 new, 2 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Nantahala Capital Management, LLC
Joint filing with Harkey Wilmot B. (14.40%), Mack Daniel (14.40%)
1,086,81214.40%13D (active) amendmentJun 6, 2025
Lytton Laurence W
Joint filing with Lytton-Kambara Foundation (8.80%)
1,071,3519.99%13G (passive) amendmentDec 31, 2025
Stonepine Capital Management, LLC
Joint filing with Stonepine Capital, L.P. (9.90%), Stonepine GP, LLC (9.90%) and 1 more
906,0639.90%13G (passive) amendmentJun 30, 2025
Kanen David
Joint filing with Kanen Wealth Management LLC (10.30%), Philotimo Fund, LP (6.90%)
635,07310.30%13G (passive) amendmentMay 15, 2025
AWM Investment Company, Inc.619,5745.80%13G (passive) amendmentDec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of AYTUValueChange% of portfolio
Nantahala Capital Management, LLC2,173,62420.00%$4.67M+1,086,8120.08%
Stonepine Capital Management, LLC912,9218.40%$1.96M+120,6321.11%
AWM Investment Company, Inc.619,5745.70%$1.33M–0.12%
Vanguard Capital Management LLC261,1462.40%$561.46K–0.00%
Crown Advisors Management, Inc.200,0001.84%$430.00K+55,0000.24%
Diadema Partners LP148,5461.37%$319.37K−204,5310.04%
Two Sigma Investments, LP105,3260.97%$226.45K−16,6470.00%
Renaissance Technologies LLC104,8230.96%$225.37K+11,1000.00%
Geode Capital Management, LLC93,6470.86%$201.37K+1,0110.00%
Citadel Advisors LLC49,4140.45%$106.24K+12,5730.00%
Vanguard Fiduciary Trust Co47,0480.43%$101.15K–0.00%
Dimensional Fund Advisors LP45,3260.42%$97.45K+1,7410.00%
Persistent Asset Partners Ltd37,9840.35%$81.67K−54,9130.02%
Northern Trust Corp27,9250.26%$60.04K+8,7560.00%
Bellevue Asset Management, LLC25,0130.23%$53.78K–0.02%
BlackRock, Inc.22,7930.21%$49.01K–0.00%
XTX Topco Ltd21,4160.20%$46.04K−1660.00%
Acadian Asset Management LLC10,2370.09%$22.00K–0.00%
Daytona Street Capital LLC10,0000.09%$22.35K–0.02%
UBS Group AG2,3770.02%$5.11K+7140.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026385M45.3%3 / 125 / 21M0M
Q1 2026374M35.9%6 / 95 / 51M0M
Q4 2025394M34.7%9 / 96 / 30M0M
Q3 2025334M32.9%6 / 93 / 41M1M
Q2 2025323M31.4%7 / 56 / 52M0M
Q1 2025312M17.3%7 / 62 / 50M0M
Q4 2024292M17.3%7 / 55 / 20M0M
Q3 2024242M18.9%1 / 48 / 30M1M
Q2 2024273M28.9%3 / 76 / 31M0M
Q1 2024272M16.5%6 / 75 / 10M1M
Q4 2023223M26.4%2 / 96 / 21M0M
Q3 2023222M15.9%3 / 56 / 20M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

15 funds held AYTU in Q2 2026, 76% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of AYTUValue% of fundAs of
Vanguard Total Stock Market Index Fund169,0001.56%$363.35K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund92,1460.85%$198.11K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund50,2290.46%$115.02K0.00%May 31, 2026
Fidelity Series Total Market Index Fund11,9290.11%$27.32K0.00%May 31, 2026
Fidelity Total Market Index Fund9,7570.09%$22.34K0.00%May 31, 2026
U.S. Vector Equity Portfolio5,4810.05%$12.22K0.00%Jul 31, 2026
Dimensional US Sustainability Core 1 ETF4,8050.04%$10.72K0.00%Jul 31, 2026
U.S. Sustainability Core 1 Portfolio4,6400.04%$10.35K0.00%Jul 31, 2026
Dimensional U.S. Small Cap ETF4,4020.04%$9.82K0.00%Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF4,1220.04%$9.19K0.00%Jul 31, 2026
U.S. Core Equity 1 Portfolio4,1000.04%$9.14K0.00%Jul 31, 2026
Dimensional US Core Equity 1 ETF2,1470.02%$4.79K0.00%Jul 31, 2026
U.S. Social Core Equity 2 Portfolio1,7410.02%$3.88K0.00%Jul 31, 2026
U.S. Core Equity 2 Portfolio1,7100.02%$3.81K0.00%Jul 31, 2026
Omni Small-Cap Value Fund1,5000.01%$3.23K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Joshua R. DisbrowChief Executive Officer, Director237,2032.18%Jul 30, 2026
Greg PyszczymukaChief Commercial Officer56,1020.52%Jul 30, 2026
Jarrett DisbrowChief Business Officer76,5680.70%Jul 30, 2026
Ryan J. SelhornChief Financial Officer74,7430.69%Jul 30, 2026
Vivian H. LiuDirector29,8250.27%Jul 30, 2026
Carl DockeryDirector31,2020.29%Jul 30, 2026
John Donofrio Jr.Director23,7620.22%Jul 30, 2026
Abhinav JainDirector29,5000.27%Jul 30, 2026
Nantahala Capital Management, LLC10% owner1,086,81210.00%Jun 9, 2025
Daniel Mack10% owner––Jun 9, 2025
Wilmot B. Harkey10% owner––Jun 9, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ryan J. Selhorn
Chief Financial Officer
Jul 28, 2026Award+25,000––74,743
Jarrett Disbrow
Chief Business Officer
Jul 28, 2026Award+15,000––76,568
Abhinav Jain
Director
Jul 28, 2026Award+10,000––29,500
John Donofrio Jr.
Director
Jul 28, 2026Award+10,000––23,762
Joshua R. Disbrow
Chief Executive Officer, Director
Jul 28, 2026Award+30,000––237,203
Greg Pyszczymuka
Chief Commercial Officer
Jul 28, 2026Award+20,000––56,102
Carl Dockery
Director
Jul 28, 2026Award+10,000––31,152
Vivian H. Liu
Director
Jul 28, 2026Award+10,000––29,825
Greg Pyszczymuka
Chief Commercial Officer
Oct 3, 2025Award+12,500––36,102
Vivian H. Liu
Director
Oct 3, 2025Award+10,000––19,825
Ryan J. Selhorn
Chief Financial Officer
Oct 3, 2025Award+17,500––49,743
Ryan J. Selhorn
Chief Financial Officer
Oct 3, 2025Award+16,243––32,243
Carl Dockery
Director
Oct 3, 2025Award+10,000––20,440
Joshua R. Disbrow
Chief Executive Officer, Director
Oct 3, 2025Award+22,500––207,203
Joshua R. Disbrow
Chief Executive Officer, Director
Oct 3, 2025Award+31,446––184,703
John Donofrio Jr.
Director
Oct 3, 2025Award+10,000––13,762
Abhinav Jain
Director
Oct 3, 2025Award+10,000––19,500
Jarrett Disbrow
Chief Business Officer
Oct 3, 2025Award+19,606––49,068
Jarrett Disbrow
Chief Business Officer
Oct 3, 2025Award+12,500––61,568
Joshua R. Disbrow
Chief Executive Officer
Jun 9, 2025Buy+66,666$1.50$100.00K153,257
Jarrett Disbrow
Chief Business Officer
Jun 9, 2025Buy+16,666$1.50$25.00K29,462
Greg Pyszczymuka
Chief Commercial Officer
Mar 31, 2025Option exercise+209––23,602
Joshua R. Disbrow
Chief Executive Officer
Feb 28, 2025Buy+15,000$1.30$19.50K86,591
Ryan J. Selhorn
Chief Financial Officer
Feb 5, 2025Option exercise+105––16,000
Greg Pyszczymuka
Chief Commercial Officer
Dec 31, 2024Option exercise+208––23,393
Ryan J. Selhorn
Chief Financial Officer
Nov 11, 2024Award+14,000––15,895
Vivian H. Liu
Director
Nov 6, 2024Award+1,500––9,825
Abhinav Jain
Director
Nov 6, 2024Award+1,500––9,500
Carl Dockery
Director
Nov 6, 2024Award+1,500––10,440
John Donofrio Jr.
Director
Nov 6, 2024Award+1,500––3,762
Greg Pyszczymuka
Chief Commercial Officer
Sep 30, 2024Option exercise+209––23,185
Greg Pyszczymuka
Chief Commercial Officer
Jun 30, 2024Option exercise+208––22,976
Greg Pyszczymuka
Chief Commercial Officer
Mar 31, 2024Option exercise+208––22,768
Greg Pyszczymuka
Chief Commercial Officer
Dec 31, 2023Option exercise+209––22,560
Greg Pyszczymuka
Chief Commercial Officer
Sep 30, 2023Option exercise+208––22,351
Abhinav Jain
Director
Aug 16, 2023Award+6,500––8,000
Vivian H. Liu
Director
Aug 11, 2023Award+1,500––8,325
John Donofrio Jr.
Director
Aug 11, 2023Award+1,500––2,262
Carl Dockery
Director
Aug 11, 2023Award+1,500––8,940
Vivian H. Liu
Director
Aug 11, 2023Award+1,500––1,841
Abhinav Jain
Director
Aug 11, 2023Award+1,500––1,500
Greg Pyszczymuka
Chief Commerical Officer
Jun 30, 2023Option exercise+208––22,143
Greg Pyszczymuka
Chief Commerical Officer
Jun 16, 2023Buy+12,000$1.87$22.44K21,935
Joshua R. Disbrow
Chief Executive Officer, Director
Jun 14, 2023Buy+14,000$1.86$26.04K71,591
Greg Pyszczymuka
Chief Commerical Officer
Apr 25, 2023Option exercise+833––9,935
Vivian H. Liu
Director
Feb 8, 2023Award+6,500––6,825
John Donofrio Jr.
Director
Dec 21, 2022Returned to company−187,804––15,267
Carl Dockery
Director
Dec 21, 2022Returned to company−40,000––148,805
Gary Cantrell
Director
Dec 21, 2022Returned to company−40,000––164,089
Joshua R. Disbrow
Chief Executive Officer, Director
Dec 20, 2022Returned to company−80,000––1,151,877
Joshua R. Disbrow
Chief Executive Officer, Director
Dec 19, 2022Buy+112,371$0.22$24.72K1,231,877
Greg Pyszczymuka
Chief Commercial Officer
Dec 19, 2022Buy+100,000$0.24$24.00K182,056
Mark K. Oki
Chief Financial Officer
Nov 18, 2022Buy+90,000$0.23$20.70K190,000
Joshua R. Disbrow
Chief Executive Officer, Director
Nov 18, 2022Buy+222,000$0.24$53.28K1,119,506
Joshua R. Disbrow
Chief Executive Officer, Director
Nov 18, 2022Award+222,000$0.24$53.28K1,119,506
Mark K. Oki
Chief Financial Officer
Nov 18, 2022Award+90,000$0.23$20.70K190,000
Vivian H. Liu
Director
Jul 1, 2022Award+6,500––6,500
Mark K. Oki
Chief Financial Officer
Jan 17, 2022Award+100,000––100,000
John Donofrio Jr.
Director
Apr 16, 2021Award+187,804––203,071
Gary Cantrell
Director
Apr 16, 2021Award+187,804––204,089

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.27%
0M shares short
Days to cover
11.7
At 0M shares a day
Change since last report
-8.3%
From 0M shares
Short volume, 20 days
36.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aytu BioPharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 12,426 shares on Sep 23, 2026 over the last 90 days.

See a number that looks wrong?